Community-Driven strategies aim to end intergenerational type 2 diabetes in indigenous children

NCT ID NCT07692321

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study works with First Nations communities in Manitoba to design and test ways to prevent type 2 diabetes in children. Pregnant women with or without diabetes are enrolled, and their children are followed from birth. The approach includes breastfeeding support, nutrition and activity guidance, and early screening for blood sugar problems using HbA1c tests and continuous glucose monitors. The goal is to stop the cycle of diabetes passing from one generation to the next.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Breastfeeding and perinatal education and support program; HbA1c screening machines; continuous glucose monitors
What this could lead to
If successful, this could help break the cycle of type 2 diabetes in Indigenous communities by preventing the disease in children from birth.
What could go wrong
This is an observational and co-design study, not a controlled trial, so it may not prove which specific intervention works best. Results depend on community engagement and long-term follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS (GDM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital Research Institute of Manitoba/University of Manitoba

    Winnipeg, Manitoba, R3E 3P4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.